It has been documented that GA administration can stabilize OS and alleviate neuroinflammation, resulting in improved neurodegeneration by increasing antioxidant enzyme brain expression (CAT, GSH, SOD, GPx1, and SOD1) and decreasing reactive astrocytes and microglia cell activation in AD animal models. The gene discussed is SOD1; the disease is Alzheimer disease.